Joshua LaBaer, MD, Ph.D.
Biodesign Institute
Francis Eshun, MD
Hematology/Oncology
David Carpentieri, MD
Pathology
Looking to identify the phosphorylation sites of a protein over expressed in high risk/poor outcome neuroblastoma patients
Joshua LaBaer, MD, Ph.D.
Biodesign Institute
Francis Eshun, MD
Hematology/Oncology
David Carpentieri, MD
Pathology
Looking to identify the phosphorylation sites of a protein over expressed in high risk/poor outcome neuroblastoma patients